The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Identification of Domains of the Insulin-Like Growth Factor I Receptor That Are Required for Protection from Apoptosis
Open accessAbstract
Using a series of insulin-like growth factor I (IGF-I) receptor mutants, we have attempted to define domains required for transmitting the antiapoptotic signal from the receptor and to compare these domains with those required for mitogenesis or transformation. In FL5.12 cells transfected with wild-type IGF-I receptors, IGF-I affords protection from interleukin 3 withdrawal but is not mitogenic. An IGF-I receptor lacking a functional ATP binding site provided no protection from apoptosis. However, receptors mutated at tyrosine residue 950 or in the tyrosine cluster (1131, 1135, and 1136) within the kinase domain remained capable of suppressing apoptosis, although such mutations are known to inactivate transforming and mitogenic functions. In the C terminus of the IGF-I receptor, two mutations, one at tyrosine 1251 and one which replaced residues histidine 1293 and lysine 1294, abolished the antiapoptotic function, whereas mutation of the four serines at 1280 to 1283 did not. Interestingly, receptors truncated at the C terminus had enhanced antiapoptotic function. In Rat-1/ c-MycER fibroblasts, the Y950F mutant and the tyrosine cluster mutant could still provide protection from c-Myc-induced apoptosis, whereas mutant Y1250/1251F could not. These studies demonstrate that the domains of the IGF-I receptor required for its antiapoptotic function are distinct from those required for its proliferation or transformation functions and suggest that domains of the receptor required for inhibition of apoptosis are necessary but not sufficient for transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Self-citationUllrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,844
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Self-citationCooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Self-citationc-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
Harrington, E. A., Bennett, M. R., Fanidi, A., & Evan, G. I. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06630.x · Cited by 742
Self-citationInduction of apoptosis by the Bcl-2 homologue Bak
Chittenden, T., Harrington, E. A., O'Connor, R., Remington, C., Lutz, R. J., Evan, G. I., & Guild, B. C. (1995) · Nature · doi:10.1038/374733a0 · Cited by 731
Self-citationMultiple extracellular signals are required for long-term oligodendrocyte survival
Barres, B. A., Schmid, R., Sendnter, M., & Raff, M. C. (1993) · Development · doi:10.1242/dev.118.1.283 · Cited by 712
Cited by
MOHAN, S., & BAYLINK, D. J. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199102000-00004 · Cited by 519
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., & Baserga, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7203 · Cited by 498
Self-citationAl-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C., & Pijnenborg, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem011 · Cited by 486
40 YEARS OF IGF1: IGF1 receptor signaling pathways
Hakuno, F., & Takahashi, S.-I. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0311 · Cited by 452
The IGF-I receptor in cell growth, transformation and apoptosis
Baserga, R., Hongo, A., Rubini, M., Prisco, M., & Valentinis, B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00007-3 · Cited by 439
Self-citationMechanisms of apoptosis by c-Myc
Prendergast, G. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202727 · Cited by 430
Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix
Sperandio, S., Poksay, K., de Belle, I., Lafuente, M. J., Liu, B., Nasir, J., & Bredesen, D. E. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401465 · Cited by 401
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
Facchini, L. M., & Penn, L. Z. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.633 · Cited by 377
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
Ren, J., Samson, W. K., & Sowers, J. R. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1036 · Cited by 304
Laviola, L., Natalicchio, A., & Giorgino, F. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249146 · Cited by 296
The IGF-I Receptor in Cancer Research
Baserga, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4667 · Cited by 292
Self-citationControl of cell survival by IGF signaling pathways
Vincent, A. M., & Feldman, E. L. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00017-5 · Cited by 289
Hughes, P. E., Alexi, T., Walton, M., Williams, C. E., Dragunow, M., G. Clark, R., & Gluckman, P. D. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00057-4 · Cited by 253
Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu, J. D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., & Plymate, S. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20929 · Cited by 188
Cellular lifespan and senescence signaling in embryonic stem cells
Miura, T., Mattson, M. P., & Rao, M. S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00134.x · Cited by 102
Zebrafish insulin-like growth factor-I receptor: molecular cloning and developmental expression
Ayaso, E., Nolan, C. M., & Byrnes, L. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00083-7 · Cited by 41
Metadata
- Authors
- O’Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., & Blättler, W. A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1997-01-01
- Volume
- 17
- Issue
- 1
- Pages
- 427-435
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2140884727
- Cited by
- 255
- References
- 41
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.